• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Cardiology

Midlife vascular risk factors linked with higher brain amyloid in later life

byMichael MilliganandDaniel Fisher
April 15, 2017
in Cardiology, Chronic Disease, Imaging and Intervention, Neurology
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. In this prospective cohort study, the presence of vascular risk factors during midlife were associated with higher brain amyloid in later life.

2. Higher midlife BMI was associated with higher amyloid burden in later life.

Evidence Rating Level: 2 (Good)

Study Rundown: Many preclinical studies have found evidence of an association between vascular health and Alzheimer’s Disease (AD). However, the nature of the relationship remains unclear. As such, this multicenter, prospective cohort study sought to determine if vascular risk factors in mid or late life are associated with amyloid content—and thus AD—in the cerebral cortex. The results showed that patients with 2 or more vascular risk factors in midlife were more likely to have higher amyloid burden, as determined by non-invasive imaging, later in life when compared to those without risk factors. Vascular risk factors in later life failed to reach significance for an association with amyloid burden. In particular, high BMI during midlife was independently associated with a high later life amyloid burden.

While this study lends support to the hypothesis that vascular health and AD pathogenesis may be directly linked, lack of statistical power leaves many important questions unanswered. For instance, while the incidence of AD is thought to be equal among sexes, the true prevalence is enriched among women. This phenomenon has led many investigators to hypothesize that AD may be driven by an intrinsic biological mechanism. One (of many) way in which men and women differ is in vascular health. However, this study was unable to resolve the interaction between sex and vascular health and their shared impact on the pathogenesis of AD. Doing so would have greatly added to the understanding of AD. All in all, this study sheds light on the association between AD and vascular health, and will hopefully inspire future studies to investigate this linkage in more depth.

Click to read the study, published in JAMA

Relevant Reading: Stroke risk interacts with Alzheimer’s disease biomarkers on brain aging outcomes

RELATED REPORTS

#VisualAbstract: Anti-tau antibody Semorinemab not shown to slow clinical progression of Alzheimer’s disease

Anti-tau antibody Semorinemab not shown to slow clinical progression of Alzheimer’s disease

Decline in gait speed paired with domain-specific cognition decline may be a useful screening assessment for dementia

In-Depth [prospective cohort]: Participants in the Atherosclerosis Risk in Communities (ARIC) Study were recruited at a mean age of 52 and followed until 76, when Florbetapir PET imaging was undertaken. 322 out of 346 patients who underwent imaging were sorted into low or high amyloid burden groups using the median Standardized Uptake Value Ratios (SUVR) of 1.2. Those with 2 or more vascular risk factors in midlife were more likely to have high amyloid burdens compared to those with none (Difference of 30.4%; CI95 16.4%-44.3; OR 2.88; CI95 1.46 to 5.69). Each additional vascular risk factor conferred an increased Odds Ratio of 1.41 (CI95 1.09-1.83). Have 2 or more late life vascular risk factors did not reach statistical significance in amyloid burden compared to having 0 risk factors (p > 0.05). Elevated midlife BMI was associated with having a high amyloid burden (OR 2.06; CI95 1.16-3.65), but not other vascular risk factor or any late life vascular risk factor reached significance. No interactions between vascular risk factors and race, sex, or APOE4 status were able to reach statistical significance for high amyloid burden (p > 0.05). Sensitivity analyses using SUVR cutoffs of 1.10 or 1.11 did not alter the results significantly.

 

Image: PD

©2017 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: amyloidcardiovascular riskdementia
Previous Post

Spinal manipulative therapy linked to modest improvements in pain and function for acute low back pain

Next Post

Wide surgical excision is effective in the treatment of subungual squamous cell carcinoma

RelatedReports

#VisualAbstract: Varenicline improves successful smoking cessation amongst African American daily smokers: KIS-IV Trial
StudyGraphics

#VisualAbstract: Anti-tau antibody Semorinemab not shown to slow clinical progression of Alzheimer’s disease

June 29, 2022
Genetic risk assessment for Alzheimer’s disease does not increase anxiety, depression or stress
Chronic Disease

Anti-tau antibody Semorinemab not shown to slow clinical progression of Alzheimer’s disease

June 17, 2022
Chronic Disease

Decline in gait speed paired with domain-specific cognition decline may be a useful screening assessment for dementia

May 31, 2022
FDA-approved weight loss medications associated with weight loss at one year
Cardiology

Mediterranean diet superior to low-fat diet in secondary prevention of cardiovascular events

May 25, 2022
Next Post
Wide surgical excision is effective in the treatment of subungual squamous cell carcinoma

Wide surgical excision is effective in the treatment of subungual squamous cell carcinoma

Paternal factors associated with short interpregnancy interval

MĂĽllerian inhibiting substance is a safe contraceptive that prevents chemotherapy-induced infertility [PreClinical]

Parental immunization status associated with likelihood of vaccinating children

Parental immunization status associated with likelihood of vaccinating children

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Ciprofol comparable to propofol for general anesthesia induction for gynecological surgery
  • Moderate-intensity statin plus ezetimibe is non-inferior to high-intensity statin monotherapy
  • Type of compensation model influences gender pay gap in primary care
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.